Skip to main content

Resveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression

A Correction to this article was published on 31 August 2018

This article has been updated


Stress hormone norepinephrine (NE) has been associated with acquisition of cancer progression, and naturally occurring phytoalexin resveratrol (REV) has been known to suppress cancer growth and progression. In the present study, we determine the effect of REV on NE-induced ovarian cancer invasiveness. Pretreatment of REV significantly inhibited NE-induced ovarian cancer cell epithelial-to-mesenchymal transition with concomitant recovery of E-cadherin expression. In addition, our data showed that REV downregulates NE-induced human telomerase reverse transcriptase (hTERT) expression through inhibiting Src phosphorylation and HIF-1α expression. Further, REV reduced NE-induced Slug expression and subsequent ovarian cancer invasion. More importantly, combined treatment of REV with a pharmacological inhibitor of beta adrenergic receptor significantly attenuated NE-induced ovarian cancer invasion compared to single treatment. Therefore, we demonstrate interference of a Src and HIF-1α/hTERT/Slug signaling cascade by REV, providing potential therapeutic targets and inhibition of ovarian cancer.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Change history

  • 31 August 2018

    Unfortunately, there are some errors in Fig. 1b and Fig. 3a of the article.


  • Armaiz-Pena, G.N., J.K. Allen, A. Cruz, R.L. Stone, A.M. Nick, Y.G. Lin, L.Y. Han, L.S. Mangala, G.J. Villares, P. Vivas-Mejia, C. Rodriguez-Aguayo, A.S. Nagaraja, K.M. Gharpure, Z. Wu, R.D. English, K.V. Soman, M.M. Shazhad, M. Zigler, M.T. Deavers, A. Zien, T.G. Soldatos, D.B. Jackson, J.E. Wiktorowicz, M. Torres-Lugo, T. Young, K. De Geest, G.E. Gallick, M. Bar-Eli, G. Lopez-Berestein, S.W. Cole, G.E. Lopez, S.K. Lutgendorf, and A.K. Sood. 2013. Src activation by beta-adrenoreceptors is a key switch for tumour metastasis. Nature Communications 4: 1403.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Baribeau, S., P. Chaudhry, S. Parent, and E. Asselin. 2014. Resveratrol inhibits cisplatin-induced epithelial-to-mesenchymal transition in ovarian cancer cell lines. PLoS One 9: e86987.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Choi, M.J., K.H. Cho, S. Lee, Y.J. Bae, K.J. Jeong, S.Y. Rha, E.J. Choi, J.H. Park, J.M. Kim, J.S. Lee, G.B. Mills, and H.Y. Lee. 2015. hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness. Oncogene 34: 3402–3412.

    Article  PubMed  CAS  Google Scholar 

  • De Craene, B., B. Gilbert, C. Stove, E. Bruyneel, F. van Roy, and G. Berx. 2005. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Research 65: 6237–6244.

    Article  PubMed  Google Scholar 

  • Gallo, D., C. Ferlini, and G. Scambia. 2010. The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer. Current Drug Targets 11: 474–481.

    Article  PubMed  CAS  Google Scholar 

  • Gardner, M.J., L.M. Jones, J.B. Catterall, and G.A. Turner. 1995. Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Letters 91: 229–234.

    Article  PubMed  CAS  Google Scholar 

  • Hajra, K.M., D.Y. Chen, and E.R. Fearon. 2002. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Research 62: 1613–1618.

    PubMed  CAS  Google Scholar 

  • Hassan, S., Y. Karpova, D. Baiz, D. Yancey, A. Pullikuth, A. Flores, T. Register, J.M. Cline, R. D’Agostino Jr, N. Danial, S.R. Datta, and G. Kulik. 2013. Behavioral stress accelerates prostate cancer development in mice. The Journal of Clinical Investigation 123: 874–886.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Hu, F.W., L.L. Tsai, C.H. Yu, P.N. Chen, M.Y. Chou, and C.C. Yu. 2012. Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. Molecular Nutrition & Food Research 56: 1247–1258.

    Article  CAS  Google Scholar 

  • Jang, M., L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218–220.

    Article  PubMed  CAS  Google Scholar 

  • Jeong, K.J., S.Y. Park, K.H. Cho, J.S. Sohn, J. Lee, Y.K. Kim, J. Kang, C.G. Park, J.W. Han, and H.Y. Lee. 2012. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion. Oncogene 31: 4279–4289.

    Article  PubMed  CAS  Google Scholar 

  • Kotha, A., M. Sekharam, L. Cilenti, K. Siddiquee, A. Khaled, A.S. Zervos, B. Carter, J. Turkson, and R. Jove. 2006. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Molecular Cancer Therapeutics 5: 621–629.

    Article  PubMed  CAS  Google Scholar 

  • Lang, K., T.L. Drell, A. Lindecke, B. Niggemann, C. Kaltschmidt, K.S. Zaenker, and F. Entschladen. 2004. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. International Journal of Cancer 112: 231–238.

    Article  PubMed  CAS  Google Scholar 

  • Lanzilli, G., M.P. Fuggetta, M. Tricarico, A. Cottarelli, A. Serafino, R. Falchetti, G. Ravagnan, M. Turriziani, R. Adamo, O. Franzese, and E. Bonmassar. 2006. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. International Journal of Oncology 28: 641–648.

    PubMed  CAS  Google Scholar 

  • Lara, H.E., A. Porcile, J. Espinoza, C. Romero, S.M. Luza, J. Fuhrer, C. Miranda, and L. Roblero. 2001. Release of norepinephrine from human ovary: Coupling to steroidogenic response. Endocrine 15: 187–192.

    Article  PubMed  CAS  Google Scholar 

  • Lara, H.E., M. Dorfman, M. Venegas, S.M. Luza, S.L. Luna, A. Mayerhofer, M.A. Guimaraes, E.S.A.A. Rosa, and V.D. Ramirez. 2002. Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release. Microscopy Research and Technique 59: 495–502.

    Article  PubMed  CAS  Google Scholar 

  • Liu, Z., Q. Li, K. Li, L. Chen, W. Li, M. Hou, T. Liu, J. Yang, C. Lindvall, M. Bjorkholm, J. Jia, and D. Xu. 2012. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells. Oncogene 32: 4203–4213.

    Article  PubMed  CAS  Google Scholar 

  • Lutgendorf, S.K., S. Cole, E. Costanzo, S. Bradley, J. Coffin, S. Jabbari, K. Rainwater, J.M. Ritchie, M. Yang, and A.K. Sood. 2003. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clinical Cancer Research 9: 4514–4521.

    PubMed  CAS  Google Scholar 

  • McEwen, B.S. 2002. Sex, stress and the hippocampus: Allostasis, allostatic load and the aging process. Neurobiology of Aging 23: 921–939.

    Article  PubMed  CAS  Google Scholar 

  • Nilsson, M.B., G. Armaiz-Pena, R. Takahashi, Y.G. Lin, J. Trevino, Y. Li, N. Jennings, J. Arevalo, S.K. Lutgendorf, G.E. Gallick, A.M. Sanguino, G. Lopez-Berestein, S.W. Cole, and A.K. Sood. 2007. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. Journal of Biological Chemistry 282: 29919–29926.

    Article  PubMed  CAS  Google Scholar 

  • Ozols, R.F., M.A. Bookman, D.C. Connolly, M.B. Daly, A.K. Godwin, R.J. Schilder, X. Xu, and T.C. Hamilton. 2004. Focus on epithelial ovarian cancer. Cancer Cell 5: 19–24.

    Article  PubMed  CAS  Google Scholar 

  • Palm, D., K. Lang, B. Niggemann, T.L. Drell, K. Masur, K.S. Zaenker, and F. Entschladen. 2006. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. International Journal of Cancer 118: 2744–2749.

    Article  PubMed  CAS  Google Scholar 

  • Park, S.Y., K.J. Jeong, J. Lee, D.S. Yoon, W.S. Choi, Y.K. Kim, J.W. Han, Y.M. Kim, B.K. Kim, and H.Y. Lee. 2007. Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: Their inhibition by resveratrol. Cancer Letters 258: 63–69.

    Article  PubMed  CAS  Google Scholar 

  • Park, S.Y., J.H. Kang, K.J. Jeong, J. Lee, J.W. Han, W.S. Choi, Y.K. Kim, J. Kang, C.G. Park, and H.Y. Lee. 2011. Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1alpha protein-dependent mechanism. International Journal of Cancer 128: 2306–2316.

    Article  PubMed  CAS  Google Scholar 

  • Shahzad, M.M., J.M. Arevalo, G.N. Armaiz-Pena, C. Lu, R.L. Stone, M. Moreno-Smith, M. Nishimura, J.W. Lee, N.B. Jennings, J. Bottsford-Miller, P. Vivas-Mejia, S.K. Lutgendorf, G. Lopez-Berestein, M. Bar-Eli, S.W. Cole, and A.K. Sood. 2010. Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. Journal of Biological Chemistry 285: 35462–35470.

    Article  PubMed  CAS  Google Scholar 

  • Siegel, R., C. Desantis, K. Virgo, K. Stein, A. Mariotto, T. Smith, D. Cooper, T. Gansler, C. Lerro, S. Fedewa, C. Lin, C. Leach, R.S. Cannady, H. Cho, S. Scoppa, M. Hachey, R. Kirch, A. Jemal, and E. Ward. 2012. Cancer treatment and survivorship statistics, 2012. CA: A Cancer Journal for Clinicians 62: 220–241.

    Google Scholar 

  • Sood, A.K., R. Bhatty, A.A. Kamat, C.N. Landen, L. Han, P.H. Thaker, Y. Li, D.M. Gershenson, S. Lutgendorf, and S.W. Cole. 2006. Stress hormone-mediated invasion of ovarian cancer cells. Clinical Cancer Research 12: 369–375.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Thaker, P.H., L.Y. Han, A.A. Kamat, J.M. Arevalo, R. Takahashi, C. Lu, N.B. Jennings, G. Armaiz-Pena, J.A. Bankson, M. Ravoori, W.M. Merritt, Y.G. Lin, L.S. Mangala, T.J. Kim, R.L. Coleman, C.N. Landen, Y. Li, E. Felix, A.M. Sanguino, R.A. Newman, M. Lloyd, D.M. Gershenson, V. Kundra, G. Lopez-Berestein, S.K. Lutgendorf, S.W. Cole, and A.K. Sood. 2006. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nature Medicine 12: 939–944.

    Article  PubMed  CAS  Google Scholar 

  • Vergara, D., C.M. Valente, A. Tinelli, C. Siciliano, V. Lorusso, R. Acierno, G. Giovinazzo, A. Santino, C. Storelli, and M. Maffia. 2011. Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells. Cancer Letters 310: 1–8.

    Article  PubMed  CAS  Google Scholar 

  • Wang, H., H. Zhang, L. Tang, H. Chen, C. Wu, M. Zhao, Y. Yang, X. Chen, and G. Liu. 2013. Resveratrol inhibits TGF-beta1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology 303: 139–146.

    Article  PubMed  CAS  Google Scholar 

  • Xia, L., X.X. Wang, X.S. Hu, X.G. Guo, Y.P. Shang, H.J. Chen, C.L. Zeng, F.R. Zhang, and J.Z. Chen. 2008. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. British Journal of Pharmacology 155: 387–394.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yang, J., S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, and R.A. Weinberg. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927–939.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, Q., X. Tang, Q.Y. Lu, Z.F. Zhang, J. Brown, and A.D. Le. 2005. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Molecular Cancer Therapeutics 4: 1465–1474.

    Article  PubMed  CAS  Google Scholar 

Download references


This study was supported by a Grant from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2014R1A2A1A01004363, NRF-2013R1A1A2A10059565, NRF-2014R1A2A1A11051091).

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Gang Min Hur or Hoi Young Lee.

Ethics declarations

Conflict of Interest

The authors disclose no potential conflicts of interest.

Additional information

Seung Hwa Kim and Kyung Hwa Cho have contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, S.H., Cho, K.H., Kim, Y.N. et al. Resveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression. Arch. Pharm. Res. 39, 240–248 (2016).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: